NASDAQ:EPZM

Epizyme SEC Filings & 10K Form

$8.53
+0.05 (+0.59 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.37
$8.54
50-Day Range
$6.81
$9.42
52-Week Range
$6.70
$22.00
Volume484,484 shs
Average Volume1.06 million shs
Market Capitalization$869.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.28

Epizyme (NASDAQ:EPZM) SEC Filings

DateFilerForm TypeView
05/13/2021
11:15 PM
Epizyme (Filer)
Form EFFECT
05/06/2021
6:14 AM
Epizyme (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/06/2021
6:14 AM
Epizyme (Filer)
Epizyme (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/06/2021
6:03 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
6:03 AM
Epizyme (Filer)
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
5:56 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
6:11 AM
Epizyme (Filer)
Form DEFA14A
04/29/2021
6:08 AM
Epizyme (Filer)
Form DEF 14A
04/15/2021
4:06 PM
Epizyme (Filer)
Form PRE 14A
04/07/2021
5:15 AM
Epizyme (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
6:00 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
6:00 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2021
3:30 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2021
3:30 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
4:16 PM
Epizyme (Filer)
Form 8-K/A
02/23/2021
6:18 AM
Epizyme (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/23/2021
6:03 AM
Epizyme (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2021
5:50 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
11:02 AM
Epizyme (Subject)
Form SC 13G/A
02/05/2021
3:41 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:41 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:40 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:40 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:12 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:09 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:08 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:07 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:05 PM
Epizyme (Issuer)
Vakiener Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:05 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:01 PM
Epizyme (Issuer)
Kutok Jeffery (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
7:44 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
7:42 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
7:42 PM
Epizyme (Issuer)
Vakiener Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
7:38 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
7:31 PM
Epizyme (Issuer)
Vakiener Victoria (Reporting)
Form 3/A
01/05/2021
7:32 AM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
7:15 AM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:17 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
6:00 AM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
6:05 AM
Epizyme (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
5:59 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2020
5:47 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
3:58 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:56 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2020
3:15 PM
Epizyme (Issuer)
Vakiener Victoria (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2020
3:15 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
8:30 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:15 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
6:04 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2020
5:52 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
4:04 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
3:32 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
8:04 AM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
8:01 AM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:57 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:56 AM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
7:54 AM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
5:16 AM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4/A
06/30/2020
5:10 AM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4/A
06/30/2020
5:06 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4/A
06/26/2020
6:12 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:39 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:36 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:31 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
6:52 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2020
3:23 PM
Epizyme (Issuer)
Legorreta Pablo G. (Reporting)
RP Management, LLC (Reporting)
RPI Finance Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:19 PM
Epizyme (Issuer)
Giordano Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:17 PM
Allen Andrew R (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:17 PM
Epizyme (Issuer)
Richon Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:16 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:16 PM
Bogle Grant C. (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:16 PM
Epizyme (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:15 PM
Epizyme (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:15 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:15 PM
BATE KENNETH (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2020
5:59 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2020
5:42 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2020
1:05 PM
Epizyme (Filer)
Form DEFA14A
04/06/2020
8:46 PM
Epizyme (Filer)
Form PRE 14A
04/02/2020
6:02 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
6:00 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:11 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:01 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:01 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:00 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:00 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
5:52 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:41 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2020
5:09 AM
Epizyme (Subject)
RPI Finance Trust (Filed by)
Form SC 13D/A
02/14/2020
1:59 PM
Epizyme (Subject)
Palo Alto Investors LP (Filed by)
Form SC 13G/A
02/13/2020
5:47 PM
Epizyme (Issuer)
Legorreta Pablo G. (Reporting)
RP Management, LLC (Reporting)
RPI Finance Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
1:46 PM
Epizyme (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/10/2020
4:27 PM
Celgene European Investment Co LLC (Filed by)
Epizyme (Subject)
Form SC 13G/A
02/05/2020
5:10 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:03 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:02 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:01 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:00 PM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:19 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
8:18 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.